CHI3L1 and Brain atrophy: A meta‐analysis of subjects who were non‐demented at baseline demonstrated that plasma YKL‐40 is associated with an increased risk for incident dementia, poorer cognition, and brain atrophy independent of age, sex, vascular risk factors, and APOE ε4.168